GDRX:NSD-Goodrx Holdings Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 6.38

Change

-0.03 (-0.47)%

Market Cap

USD 2.62B

Volume

0.63M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+1.93 (+2.26%)

USD 41.71B
TEM Tempus AI, Inc. Class A Common..

+0.29 (+0.64%)

USD 7.92B
HQY HealthEquity Inc

-0.90 (-1.03%)

USD 7.65B
RCM R1 RCM Inc

+0.01 (+0.07%)

USD 6.02B
WAY Waystar Holding Corp. Common S..

+0.46 (+1.64%)

USD 4.47B
BTSG BrightSpring Health Services, ..

-0.95 (-5.97%)

USD 2.71B
PRVA Privia Health Group Inc

+0.76 (+4.23%)

USD 2.09B
PINC Premier Inc

+0.12 (+0.60%)

USD 2.00B
OMCL Omnicell Inc

+12.93 (+32.23%)

USD 1.84B
CERT Certara Inc

-0.04 (-0.39%)

USD 1.84B

ETFs Containing GDRX

UKDV:LSE SPDR S&P UK Dividend Aris.. 4.97 % 0.00 %

-0.01 (0.00%)

USD 0.14B
SPYG:XETRA SPDR S&P UK Dividend Aris.. 4.97 % 0.00 %

-0.07 (0.00%)

USD 0.11B
UKDV:SW SPDR® S&P UK Dividend Ar.. 4.97 % 0.00 %

N/A

USD 0.14B
ELEC:LSE 4.64 % 0.00 %

N/A

N/A
ELEP:LSE 4.64 % 0.00 %

N/A

N/A
RNRG:LSE Global X Renewable Energy.. 4.25 % 0.00 %

N/A

USD 3.52M
ELEC:XETRA 3.94 % 0.00 %

N/A

N/A
HCLN:CA Harvest Clean Energy ETF .. 2.78 % 0.00 %

+0.05 (+0.00%)

CAD 0.02B
FCIV:CA Fidelity International Va.. 2.42 % 0.00 %

-0.19 (0.00%)

CAD 0.31B
AVDV Avantis® International S.. 0.60 % 0.00 %

-0.08 (0.00%)

USD 6.84B
SPYG:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

-0.09 (0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.78% 48% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.78% 48% F 40% F
Trailing 12 Months  
Capital Gain 26.59% 66% D+ 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.59% 66% D+ 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -19.35% 39% F 14% F
Dividend Return -19.35% 39% F 14% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.66% 61% D- 44% F
Risk Adjusted Return -46.45% 37% F 16% F
Market Capitalization 2.62B 88% B+ 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.